“There is always a possibility of policy driven action in terms of lowering rates or putting a ceiling on rates, etc so that’s something that I am always a little bit wary about. I am not very keen on hospitals but overall pure pharma, pure API, CDMO space is very interesting,.”
Subscribe To Our Free Newsletter |